New itch pill matches approved drug in body absorption test
NCT ID NCT07478133
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked if a new version of nalfurafine hydrochloride (a tablet that dissolves in the mouth) works the same as the approved drug Remitch®. It involved 72 healthy adults who took the drug under fed conditions. The goal was to see if the body absorbs both versions similarly, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangnan University Affiliated Hospital
Wuxi, Jiangsu, 214000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill stop the relentless itch of a liver disease? a major trial aims to find out.
- Scientists launch study to unravel mysterious chronic itch
- Dialysis itch relief: could a simple education program be the answer?
- Can cannabis oil stop severe itching? new trial aims to find out
- Can a simple cream soothe psoriasis itch? small trial hopes to find out
- New study aims to uncover the impact of itching in liver injury patients